2m 2m 2m 2m 2m 2m 2m
Neogenomics (NEO)
NASDAQ
$10.00-$0.12 (-1.19%)
Price as of Jun 03, 2026 7:33 PM EDT- $1.4BMarket Cap
- 35.29%1-Year Change
- Diagnostics & ResearchIndustry
Neogenomics (NEO)
$10.00-$0.12 (-1.19%)
NEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.12 | ||
Change | -$0.32 (-3.07%) | ||
Open | $10.28 | ||
High | $10.32 | ||
Low | $9.96 | ||
Previous Close | $10.44 | ||
Volume | 1,060,538 | ||
30-Day Average Volume | 1,379,412 | ||
1-Week Change | 9.17% | ||
1-Month Change | 7.20% | ||
1-Year Change | 35.29% | ||
3-Year Change | -43.72% | ||
5-Year Change | -74.86% | ||
Fundamentals | |||
Shares Outstanding | 130.2M | ||
Total Assets | $1.3B | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $186.7M | ||
Net Income | -$17.1M | ||
Free Cash Flow | -$13.1M | ||
EBIT | -$17.6M | ||
EBITDA | -$9.9M | ||
Net Working Capital | $289.1M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -157 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -104 | ||
Price/Operating Cash Flow | -168 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue